Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001165527-09-000182
Filing Date
2009-03-19
Accepted
2009-03-19 17:07:48
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE YEAR ENDED 12-31-08 g3005.txt 10-K 133467
2 CEO SECTION 302 CERTIFICATION ex31-1.txt EX-31.1 3779
3 CFO SECTION 302 CERTIFICATION ex31-2.txt EX-31.2 3761
4 CEO SECTION 906 CERTIFICATION ex32-1.txt EX-32.1 1558
5 CFO SECTION 906 CERTIFICATION ex32-2.txt EX-32.2 1548
  Complete submission text file 0001165527-09-000182.txt   145529
Mailing Address 3849 WEST 13TH AVENUE VANCOUVER A1 V6R 2S9
Business Address 3849 WEST 13TH AVENUE VANCOUVER A1 V6R 2S9 604-637-9744
Enox Biopharma Inc (Filer) CIK: 0001424860 (see all company filings)

EIN.: 260477124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53486 | Film No.: 09693978
SIC: 3841 Surgical & Medical Instruments & Apparatus